Dermavant Sciences GmbH
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Dec 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 13, 2027The maintenance fee for Novel Method of Use (US 10,376,475) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
- 1 fee due Apr 1, 2027The maintenance fee for Topical Pharmaceutical Compositions (US 10,426,743) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Use of Tapinarof for the Treatment of Atopic Dermatitis (US 11,938,099) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Process for Preparing Tapinarof (US 10,647,649) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,376,475 | Novel Method of Use In force · High confidence | In force | High confidence | |
| US 10,426,743 | Topical Pharmaceutical Compositions In force · High confidence | In force | High confidence | |
| US 11,458,108 | Topical Pharmaceutical Compositions In force · High confidence | In force | High confidence | |
| US 11,612,573 | Topical Pharmaceutical Compositions In force · High confidence | In force | High confidence | |
| US 11,622,945 | Topical Pharmaceutical Compositions In force · High confidence | In force | High confidence | |
| US 10,195,160 | Topical Pharmaceutical Compositions In force · High confidence | In force | High confidence | |
| US 10,206,925 | Topical Formulations of PDE-4 Inhibitors and Their Methods of Use In force · High confidence | In force | High confidence | |
| US 10,647,649 | Process for Preparing Tapinarof In force · High confidence | In force | High confidence | |
| US 10,961,175 | Process for Preparing Tapinarof In force · High confidence | In force | High confidence | |
| US 11,597,692 | Process for Preparing Tapinarof In force · High confidence | In force | High confidence |
Also on record, not counted in the 15: 5 patents in force now held by others · 1 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 3 abandoned · 5 no status recorded